Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis

Bile salt biotransformations by human intestinal bacteria

Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829

Identification of a nuclear receptor for bile acids

Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331

Bile Acids: Natural Ligands for an Orphan Nuclear Receptor

Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865

Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis

Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819

Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR

Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636

A G Protein-coupled Receptor Responsive to Bile Acids

Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628

Bile acids: regulation of synthesis

Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515

Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors

Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

Staudinger, J. L., Goodwin, B. J., Jones, S. A., Hawkins‐Brown, D., MacKenzie, K. I., Latour, A. M., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,378

Identification of a nuclear receptor that is activated by farnesol metabolites

Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210

Pleiotropic Roles of Bile Acids in Metabolism

de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209

Vitamin D Receptor As an Intestinal Bile Acid Sensor

Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome

Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916

Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics

Hofmann, A. F., & Hagey, L. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7568-6 · Cited by 873

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847

Review: microbial transformations of human bile acids

Guzior, D. V., & Quinn, R. A. (2021) · Microbiome · doi:10.1186/s40168-021-01101-1 · Cited by 795

Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21

Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesisPreprint

Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 714

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705

Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse

Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700

FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis

Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., Xu, H. E., Shulman, G. I., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Science · doi:10.1126/science.1198363 · Cited by 637

Intestinal transport and metabolism of bile acids

Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598

Bile Acid Physiology

Ciaula, A. D., Garruti, G., Baccetto, R., Molina‐Molina, E., Bonfrate, L., Wang, D. Q. ‐., & Portincasa, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5493 · Cited by 598

Human gut bacteria produce ΤΗ17-modulating bile acid metabolites

Paik, D., Yao, L., Zhang, Y., Bae, S., D’Agostino, G. D., Zhang, M., Kim, E., Franzosa, E. A., Avila-Pacheco, J., Bisanz, J. E., et al. (2022) · Nature · doi:10.1038/s41586-022-04480-z · Cited by 594

A metabolic pathway for bile acid dehydroxylation by the gut microbiome

Funabashi, M., Grove, T. L., Wang, M., Varma, Y., McFadden, M. E., Brown, L. C., Guo, C., Higginbottom, S., Almo, S. C., & Fischbach, M. A. (2020) · Nature · doi:10.1038/s41586-020-2396-4 · Cited by 590

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576

Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the Brain

Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 553

The nuclear receptor superfamily: A structural perspective

Weikum, E. R., Liu, X., & Ortlund, E. A. (2018) · Protein Science · doi:10.1002/pro.3496 · Cited by 542

Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation

Björkhem, I., Lütjohann, D., Diczfalusy, U., Ståhle, L., Ahlborg, G., & Wahren, J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32188-x · Cited by 538

Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR

Maloney, P., Parks, D. J., Haffner, C. D., Fivush, A. M., Chandra, G., Plunket, K. D., Creech, K. L., Moore, L. B., Wilson, J. G., Lewis, M. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002127 · Cited by 536

α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling

Chen, G., Yang, L., Goetz, R. M., Fu, L., Jayaraman, S., Hu, M. C., Moe, O. W., Liang, G., Li, X., & Mohammadi, M. (2018) · Nature · doi:10.1038/nature25451 · Cited by 501

Bile Acid Transporters: Structure, Function, Regulation and Pathophysiological Implications

Alrefai, W. A., & Gill, R. K. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9289-1 · Cited by 500

Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype

Pullinger, C. R., Eng, C. S., Salen, G., Shefer, S., BATTA, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15387 · Cited by 468

Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice

Kong, B., Wang, L., Chiang, J. Y. L., Zhang, Y., Klaassen, C. D., & Guo, G. L. (2012) · Hepatology · doi:10.1002/hep.25740 · Cited by 456

Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype

Pullinger, C. R., Eng, C. S., Salen, G., Shefer, S., BATTA, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 456

A biosynthetic pathway for a prominent class of microbiota-derived bile acids

Devlin, A. S., & Fischbach, M. A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1864 · Cited by 448

FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway

Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.019 · Cited by 431

Bile salts of vertebrates: structural variation and possible evolutionary significance

Hofmann, A. F., Hagey, L. R., & Krasowski, M. D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r000042 · Cited by 427

NGM282 for treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Harrison, S. A., Rinella, M. E., Abdelmalek, M. F., Trotter, J. F., Paredes, A. H., Arnold, H. L., Kugelmas, M., Bashir, M. R., Jaros, M. J., Ling, L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30474-4 · Cited by 425

Bile Acids as Hormones: The FXR-FGF15/19 Pathway

Kliewer, S. A., & Mangelsdorf, D. J. (2015) · Digestive Diseases · doi:10.1159/000371670 · Cited by 424

Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover

Lund, E. G., Xie, C., Kotti, T., Turley, S. D., Dietschy, J. M., & Russell, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303415200 · Cited by 421

Functional evolutionary history of the mouse Fgf gene family

Itoh, N., & Ornitz, D. M. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21388 · Cited by 416

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

Lambert, G. C., Amar, M. J., Guo, G. L., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 401

A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR

Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R. O., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 396

Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors

Seol, W., Choi, H.-S., & Moore, D. D. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.1.7760852 · Cited by 389

Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2).

Oelkers, P. M., Kirby, L. C., Heubi, J. E., & Dawson, P. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119355 · Cited by 379

A Mouse Model of Hepatocellular Carcinoma

Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J.-P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61177-7 · Cited by 359

Fifty years of advances in bile acid synthesis and metabolism

Russell, D. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800026-jlr200 · Cited by 358

THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS

Hofmann, A. (1963) · Biochemical Journal · doi:10.1042/bj0890057 · Cited by 353

Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4

Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M. B., Deng, C., & McKeehan, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15482 · Cited by 348

Conjugated Bile Acids Activate the Sphingosine–1–Phosphate Receptor 2 in Primary Rodent Hepatocytes

Studer, E. J., Zhou, X., Zhao, R., Wang, Y., Takabe, K., Nagahashi, M., Pandak, W. M., Dent, P., Spiegel, S., Shi, R., et al. (2011) · Hepatology · doi:10.1002/hep.24681 · Cited by 327

Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans

Takahashi, S., Fukami, T., Masuo, Y., Brocker, C. N., Xie, C., Krausz, K. W., Wolf, C. R., Henderson, C. J., & Gonzalez, F. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071183 · Cited by 324

Retinoid X receptors: common heterodimerization partners with distinct functions

Lefèbvre, P., Benomar, Y., & Staels, B. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.009 · Cited by 320

Cholesterol 24-Hydroxylase: an enzyme of cholesterol turnover in the brain

Russell, D. W., Halford, R. W., Ramirez, D. M. O., Shah, R., & Kotti, T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.072407.103859 · Cited by 317

Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR

Mi, L.-Z., Devarakonda, S., Harp, J. M., Han, Q., Pellicciari, R., Willson, T. M., Khorasanizadeh, S., & Rastinejad, F. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00112-6 · Cited by 315

Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation

Wärnmark, A., Treuter, E., Wright, A. P. H., & Gustafsson, J.-A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0384 · Cited by 308

Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter.

Shneider, B. L., Dawson, P. A., Christie, D. M., Hardikar, W., Wong, M. H., & Suchy, F. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117722 · Cited by 307

FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4

Xie, M.-H., Holcomb, I. N., Deuel, B., Dowd, P., Huang, A. J. Y., Vagts, A. J., Foster, J., Liang, J., Brush, J., Gu, Q., et al. (1999) · Cytokine · doi:10.1006/cyto.1999.0485 · Cited by 301

Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation

Zhang, Y., Kast-Woelbern, H. R., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209505200 · Cited by 295

Hepatic Transport of Bile Salts

Kullak-Ublick, G. A., Stieger, B., Hagenbuch, B., & Meier, P. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9426 · Cited by 292

Liver-specific Activities of FGF19 Require Klotho beta

Lin, B. C., Wang, M., Blackmore, C. A., & Desnoyers, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 288

General methods for the analysis of metabolic profiles of bile acids and related compounds in feces.

Setchell, K. D. R., Lawson, A. M., Tanida, N., & Sjövall, J. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37923-2 · Cited by 285

Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

Harrison, S. A., Neff, G., Guy, C. D., Bashir, M. R., Paredes, A. H., Frias, J. P., Younes, Z., Trotter, J. F., Gunn, N. T., Moussa, S. E., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.08.004 · Cited by 280

Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor

Laffitte, B. A., Kast-Woelbern, H. R., Nguyen, C., Zavacki, A. M., Moore, D. D., & Edwards, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10638 · Cited by 275

Human Gut Bacterial Metabolism Drives Th17 Activation and Colitis

Alexander, M., Ang, Q. Y., Nayak, R. R., Bustion, A. E., Sandy, M., Zhang, B., Upadhyay, V., Pollard, K. S., Lynch, S. V., & Turnbaugh, P. J. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2021.11.001 · Cited by 270

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models

Desnoyers, L. R., Pai, R., Ferrando, R., Hotzel, K., Le, T., Ross, J., Carano, R., D'Souza, A., Qing, J., Mohtashemi, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210623 · Cited by 266

FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia

Lan, T., Morgan, D. A., Rahmouni, K., Sonoda, J., Fu, X., Burgess, S. C., Holland, W. L., Kliewer, S. A., & Mangelsdorf, D. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.005 · Cited by 261

Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho

Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y., & Nabeshima, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23076 · Cited by 250

Farnesoid X receptor (FXR): Structures and ligands

Jiang, L., Zhang, H., Xiao, D., Wei, H., & Chen, Y. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.029 · Cited by 236

Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain

Nishimura, T., Utsunomiya, Y., Hoshikawa, M., Ohuchi, H., & Itoh, N. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00255-3 · Cited by 235

Bile acid-induced negative feedback regulation of the human ileal bile acid transporter

Neimark, E., Chen, F., Li, X., & Shneider, B. L. (2004) · Hepatology · doi:10.1002/hep.20295 · Cited by 234

A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1

McWhirter, J. R., Goulding, M., Weiner, J. A., Chun, J. J. M., & Murre, C. (1997) · Development · doi:10.1242/dev.124.17.3221 · Cited by 231

X-ray Crystal Structure of the Liver X Receptor β Ligand Binding Domain

Williams, S. P., Bledsoe, R. K., Collins, J. L., Boggs, S. D., Lambert, M. H., Miller, A. B., Moore, J. T., McKee, D. D., Moore, L. B., Nichols, J. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302260200 · Cited by 225

Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice

Benoit, B., Meugnier, E., Castelli, M., Chanon, S., Vieille-Marchiset, A., Durand, C., Bendridi, N., Pesenti, S., Monternier, P.-A., Durieux, A.-C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4363 · Cited by 225

The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes

Landrier, J., Eloranta, J. J., Vavricka, S. R., & Kullak-Ublick, G. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00430.2005 · Cited by 221

Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− ( Abcb4 −/−) mouse cholangiopathy model by promoting biliary HCO Symbol output

Baghdasaryan, A., Claudel, T., Gumhold, J., Silbert, D., Adorini, L., Roda, A., Vecchiotti, S., Gonzalez, F. J., Schoonjans, K., Strazzabosco, M., et al. (2011) · Hepatology · doi:10.1002/hep.24537 · Cited by 220

Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D

Schmidt, D. R., Holmstrom, S. R., Tacer, K. F., Bookout, A. L., Kliewer, S. A., & Mangelsdorf, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116004 · Cited by 215

Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition

Honda, A., Miyazaki, T., Iwamoto, J., Hirayama, T. T., Morishita, Y., Monma, T., Ueda, H., Mizuno, S., Sugiyama, F., Takahashi, S., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000395 · Cited by 215

Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis

Bhatnagar, S., Damron, H. A., & Hillgartner, F. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808818200 · Cited by 212

Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters

Huber, R., Murphy, K., Miao, B., Link, J. R., Cunningham, M. R., Rupar, M. J., Gunyuzlu, P. L., Haws, T. F., Kassam, A., Powell, F., et al. (2002) · Gene · doi:10.1016/s0378-1119(02)00557-7 · Cited by 210

Functional Intestinal Bile Acid 7α-Dehydroxylation by Clostridium scindens Associated with Protection from Clostridium difficile Infection in a Gnotobiotic Mouse Model

Studer, N., Desharnais, L., Beutler, M., Brugiroux, S., Miani, M. A. T., Menin, L., Schürch, C. M., McCoy, K. D., Kuehne, S. A., Minton, N. P., et al. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00191 · Cited by 209

Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine†

Thomas, A., Hart, S. N., Kong, B., Fang, J., Zhong, X., & Guo, G. L. (2009) · Hepatology · doi:10.1002/hep.23450 · Cited by 205

Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice

Uriarte, I., Fernandez-Barrena, M. G., Monte, M., Latasa, M., Chang, H. C. Y., Carotti, S., Vespasiani-Gentilucci, U., Morini, S., Vicente, E., Concepcion, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302945 · Cited by 196

Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood

Gälman, C., Arvidsson, I., Angelin, B., & Rudling, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d200043-jlr200 · Cited by 194

FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation

Wu, X., Ge, H., Lemon, B., Vonderfecht, S., Weiszmann, J., Hecht, R., Gupte, J., Hager, T., Wang, Z.-L., Lindberg, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068783 · Cited by 186

Fibroblast Growth Factor-19 Action in the Brain Reduces Food Intake and Body Weight and Improves Glucose Tolerance in Male Rats

Ryan, K. K., Kohli, R., Gutierrez-Aguilar, R., Gaitonde, S. G., Woods, S. C., & Seeley, R. J. (2013) · Endocrinology · doi:10.1210/en.2012-1891 · Cited by 185

On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation

Meaney, S., Bodin, K., Diczfalusy, U., & Björkhem, I. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200293-jlr200 · Cited by 173

A sonic hedgehog-dependent signaling relay regulates growth of diencephalic and mesencephalic primordia in the early mouse embryo

Ishibashi, M., & McMahon, A. P. (2002) · Development · doi:10.1242/dev.129.20.4807 · Cited by 172

27-Hydroxycholesterol: production rates in normal human subjects

Duane, W. C., & Javitt, N. B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33481-7 · Cited by 156

The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism

Jin, L., Feng, X., Rong, H., Pan, Z., Inaba, Y., Qiu, L., Zheng, W., Lin, S., Wang, R., Wang, Z., et al. (2013) · Nature Communications · doi:10.1038/ncomms2924 · Cited by 153

Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho

Fu, T., Choi, S., Kim, D.-H., Seok, S., Suino-Powell, K. M., Xu, H. E., & Kemper, J. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205951109 · Cited by 150

7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones

Berr, F., Kullak‐Ublick, G., Paumgartner, G., Münzing, W., & Hylemon, P. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70024-0 · Cited by 149

A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice

de Boer, J. F., Verkade, E., Mulder, N. L., de Vries, H. D., Huijkman, N., Koehorst, M., Boer, T. S., Wolters, J. C., Bloks, V. W., van de Sluis, B., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000243 · Cited by 146

Bile Acid-Induced Arrhythmia Is Mediated by Muscarinic M2 Receptors in Neonatal Rat Cardiomyocytes

Kadir, S. H. S. A., Miragoli, M., Abu‐Hayyeh, S., Moshkov, A. V., Xie, Q., Keitel, V., Nikolaev, V. O., Williamson, C., & Gorelik, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009689 · Cited by 145

Relevant use of Klotho in FGF19 subfamily signaling system in vivo

Tomiyama, K.-I., Maeda, R., Urakawa, I., Yamazaki, Y., Tanaka, T., Ito, S., Nabeshima, Y., Tomita, T., Odori, S., Hosoda, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913986107 · Cited by 144

Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction.

Wright, T. J., Ladher, R., Mcwhirter, J., Murre, C., Schoenwolf, G., & Mansour, S. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.02.003 · Cited by 144

Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice

Slijepcevic, D., Abbing, R. L. P. R., Katafuchi, T., Blank, A., Donkers, J. M., van Hoppe, S., de Waart, D. R., Tolenaars, D., van der Meer, J. H. M., Wildenberg, M. E., et al. (2017) · Hepatology · doi:10.1002/hep.29251 · Cited by 144

Nuclear Receptors HNF4α and LRH-1 Cooperate in Regulating Cyp7a1 in Vivo

Kır, S., Zhang, Y., Gerard, R. D., Kliewer, S. A., & Mangelsdorf, D. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421834 · Cited by 142

Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling

Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700130200 · Cited by 140

FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development

Borello, U., Cobos, I., Long, J. E., Murre, C., & Rubenstein, J. L. R. (2008) · Neural Development · doi:10.1186/1749-8104-3-17 · Cited by 138

Mechanisms of Weight Loss After Obesity Surgery

Akalestou, E., Miras, A. D., Rutter, G. A., & le Roux, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab022 · Cited by 136

Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition

Vaquero, J., Monte, M. J., Domínguez, M., Muntané, J., & Marı́n, J. J. G. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.022 · Cited by 134

Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation

Xu, S., Jia, P., Fang, Y., Jin, J., Sun, Z., Zhou, W., Li, J., Zhang, Y., Wang, X., Ren, T., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.01.029 · Cited by 134

Ostα-Ostβ is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver

Ballatori, N., Fang, F., Christian, W. V., Li, N., & Hammond, C. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90319.2008 · Cited by 130

Transport of side-chain oxidized oxysterols in the human circulation

Babiker, A., & Diczfalusy, U. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00047-2 · Cited by 129

Fusion with E2A Converts the Pbx1 Homeodomain Protein into a Constitutive Transcriptional Activator in Human Leukemias Carrying the t(1;19) Translocation

Lü, Q., Wright, D. D., & Kamps, M. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3938 · Cited by 128

Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice

Erickson, S. K., Lear, S. R., Deane, S., Dubrac, S., Huling, S. L., Nguyen, L., Bollineni, J. S., Shefer, S., Hyogo, H., Cohen, D. E., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200489-jlr200 · Cited by 113

Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia

Zhang, Y., Yin, L., Anderson, J., Ma, H., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083899 · Cited by 112

Structure and Expression of the Orphan Nuclear ReceptorSHP Gene

Lee, H., Lee, Y., Park, S.-H., Kim, Y. S., Park, S. H., Lee, J. W., Kwon, H. B., Soh, J., Moore, D. D., & Choi, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14398 · Cited by 109

Preference of Conjugated Bile Acids over Unconjugated Bile Acids as Substrates for OATP1B1 and OATP1B3

Suga, T., Yamaguchi, H., Sato, T., Maekawa, M., Goto, J., & Mano, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169719 · Cited by 107

Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism

Hu, X., Bonde, Y., Eggertsen, G., & Rudling, M. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12140 · Cited by 106

Physiological Role of Bile Acids Modified by the Gut Microbiome

Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 105

Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)

Wu, X., Ge, H., Lemon, B. D., Vonderfecht, S. L., Baribault, H., Weiszmann, J., Gupte, J., Gardner, J., Lindberg, R. A., Wang, Z., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009427107 · Cited by 104

Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1

Rizzolo, D., Kong, B., Taylor, R. E., Brinker, A., Goedken, M. J., Buckley, B., & Guo, G. L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.023 · Cited by 104

Fibroblast growth factor 15 deficiency impairs liver regeneration in mice

Kong, B., Huang, J., Zhu, Y., Li, G., Williams, J. A. R., Shen, S., Aleksunes, L. M., Richardson, J. R., Apte, U. M., Rudnick, D. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00337.2013 · Cited by 103

Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice

Zhang, X., Huang, S., Gao, M., Liu, J., Jia, X., Han, Q., Zheng, S., Miao, Y., Li, S., Weng, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323977111 · Cited by 102

Biogeography of microbial bile acid transformations along the murine gut

Marion, S., Desharnais, L., Studer, N., Dong, Y., Notter, M. D., Poudel, S., Menin, L., Janowczyk, A. R., Hettich, R. L., Hapfelmeier, S., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120001021 · Cited by 101

An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis

Wang, Y., Gunewardena, S., Li, F., Matye, D. J., Chen, C., Chao, X., Jung, T., Zhang, Y., Czerwiński, M., Ni, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17363-6 · Cited by 100

Getting the mOST from OST: Role of organic solute transporter, OSTα-OSTβ, in bile acid and steroid metabolism

Dawson, P. A., Hubbert, M. L., & Rao, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.06.002 · Cited by 94

The Structural Biology of the FGF19 Subfamily

Beenken, A., & Mohammadi, M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0887-1_1 · Cited by 93

A gut–brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus

Liu, S., Marcelin, G., Blouet, C., Jeong, J. H., Jo, Y., Schwartz, G. J., & Chua, S. C. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.003 · Cited by 89

Activation of the orphan receptor RIP14 by retinoids

Zavacki, A. M., Lehmann, J. M., Seol, W., Willson, T. M., Kliewer, S. A., & Moore, D. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7909 · Cited by 87

Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota

Wahlstrom, A. M., Kovatcheva‐Datchary, P., Ståhlman, M., Khan, M.-T., Bäckhed, F., & Marschall, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072819 · Cited by 87

Bile Acid Homeostasis in a Cholesterol 7α‐Hydroxylase and Sterol 27‐Hydroxylase Double Knockout Mouse Model

Rizzolo, D., Buckley, K., Kong, B., Zhan, L., Shen, J., Stofan, M., Brinker, A., Goedken, M., Buckley, B., & Guo, G. L. (2019) · Hepatology · doi:10.1002/hep.30612 · Cited by 83

FGF19 and FGF21: In NASH we trust

Talukdar, S., & Kharitonenkov, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101152 · Cited by 82

FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma

Gao, L., Lang, L., Zhao, X., Shay, C., Shull, A. Y., & Teng, Y. (2018) · Oncogene · doi:10.1038/s41388-018-0591-7 · Cited by 80

The Ileal Lipid Binding Protein Is Required for Efficient Absorption and Transport of Bile Acids in the Distal Portion of the Murine Small Intestine

Praslickova, D., Torchia, E. C., Sugiyama, M. G., Magrane, E. J., Zwicker, B. L., Kolodzieyski, L., & Agellon, L. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050810 · Cited by 75

Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A

Kim, Y.-C., Seok, S., Zhang, Y., Ma, J., Kong, B., Guo, G. L., Kemper, B., & Kemper, J. (2020) · Nature Communications · doi:10.1038/s41467-020-19803-9 · Cited by 73

Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression

Miyata, M., Takamatsu, Y., Kuribayashi, H., & Yamazoe, Y. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160093 · Cited by 72

FXR agonists for NASH: How are they different and what difference do they make?

Kremoser, C. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.03.020 · Cited by 72

Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor

Hwang, S. T., Urizar, N. L., Moore, D. D., & Henning, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.32982 · Cited by 71

Expression of Fibroblast growth factor 19 (Fgf19) during chicken embryogenesis and eye development, compared with Fgf15 expression in the mouse

Kurose, H., Bito, T., Adachi, T., Shimizu, M., Noji, S., & Ohuchi, H. (2004) · Gene Expression Patterns · doi:10.1016/j.modgep.2004.04.005 · Cited by 70

Epimerization of chenodeoxycholic acid to ursodeoxycholic acid byClostridium baratiiisolated from human feces

Lepercq, P., Gérard, P., Béguet, F., Raibaud, P., Grill, J.-P., Relano, P., Cayuela, C., & Juste, C. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09568.x · Cited by 70

A postprandial FGF19‐SHP‐LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy

Byun, S., Kim, Y., Zhang, Y., Kong, B., Guo, G. L., Sadoshima, J., Ma, J., KEMPER, B. W., & Kemper, J. K. (2017) · The EMBO Journal · doi:10.15252/embj.201695500 · Cited by 69

Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling

Kuribayashi, H., Miyata, M., Yamakawa, H., Yoshinari, K., & Yamazoe, Y. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.048 · Cited by 68

Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces

Lepercq, P. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.04.011 · Cited by 65

The central fibroblast growth factor receptor/beta klotho system: Comprehensive mapping in Mus musculus and comparisons to nonhuman primate and human samples using an automated in situ hybridization platform

Hultman, K., Scarlett, J. M., Baquero, A. F., Cornea, A. M., Zhang, Y., Salinas, C. B. G., Brown, J. M., Morton, G. J., Whalen, E. J., Grove, K. L., et al. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24668 · Cited by 65

Genome-Wide Binding and Transcriptome Analysis of Human Farnesoid X Receptor in Primary Human Hepatocytes

Zhan, L., Liu, H.-X., Fang, Y., Kong, B., He, Y.-Q., Zhong, X.-B., Fang, J.-W., Wan, Y., & Guo, G. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105930 · Cited by 62

Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges

Li, M., Wang, Q., Li, Y., Cao, S., Zhang, Y., Wang, Z., Liu, G., Li, J., & Gu, B. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107539 · Cited by 61

Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7α-hydroxylase

Li, H., Xu, G., Shang, Q., Pan, L., Shefer, S., BATTA, A. K., Bollineni, J. S., Tint, G. S., Keller, B. T., & Salen, G. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.017 · Cited by 58

FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis

Chen, T., Liu, H., Liu, Z., Li, K., Qin, R., Wang, Y., Liu, J., Li, Z., Gao, Q., Pan, C., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01850-1 · Cited by 58

Evolutionary conservation of CCND1-ORAOV1-FGF19-FGF4 locus from zebrafish to human

Katoh, M., & Katoh, M. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.1.45 · Cited by 54

On the regulatory role of side-chain hydroxylated oxysterols in the brain. Lessons from CYP27A1 transgenic and Cyp27a1(−/−) mice

Ali, Z., Heverin, M., Olin, M., Acimovic, J., Lövgren-Sandblom, A., Shafaati, M., Båvner, A., Meiner, V., Leitersdorf, E., & Björkhem, I. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034124 · Cited by 54

Detection of FGF15 in Plasma by Stable Isotope Standards and Capture by Anti-peptide Antibodies and Targeted Mass Spectrometry

Katafuchi, T., Esterházy, D., Lemoff, A. S., Ding, X., Sondhi, V., Kliewer, S. A., Mirzaei, H., & Mangelsdorf, D. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.004 · Cited by 53

Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands

Carotti, A., Marinozzi, M., Custodi, C., Cerra, B., Pellicciari, R., Gioiello, A., & Macchiarulo, A. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666141112094058 · Cited by 50

Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism

Correia, J. C., Massart, J., de Boer, J. F., Porsmyr‐Palmertz, M., Martínez-Redondo, V., Agudelo, L. Z., Sinha, I., Meierhofer, D., Ribeiro, V., Björnholm, M., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.005 · Cited by 47

Farnesoid X Receptor Activation Mediates Head-to-Tail Chromatin Looping in theNr0b2Gene Encoding Small Heterodimer Partner

Li, G., Thomas, A., Hart, S. N., Zhong, X., Wu, D., & Guo, G. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0014 · Cited by 46

Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols

Kakiyama, G., Marques, D., Takei, H., Nittono, H., Erickson, S. K., Fuchs, M. A., Rodríguez‐Agudo, D., Gil, G., Hylemon, P. B., Zhou, H., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.011 · Cited by 46

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma

Kanzaki, H., Chiba, T., Ao, J., Koroki, K., Kanayama, K., Maruta, S., Maeda, T., Kusakabe, Y., Kobayashi, K., Kanogawa, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84117-9 · Cited by 44

Hepatic Farnesoid X-Receptor Isoforms α2 and α4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice

Boesjes, M., Bloks, V. W., Hageman, J., Bos, T., van Dijk, T. H., Havinga, R., Wolters, H., Jonker, J. W., Kuipers, F., & Groen, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115028 · Cited by 43

The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma

Chen, Z., Jiang, L., Liang, L., Koral, K., Zhang, Q., Zhao, L., Lu, S., & Tao, J. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.014 · Cited by 43

Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma

Liu, X., Zhang, X., Ji, L., Gu, J., Zhou, M., & Chen, S. (2015) · Oncotarget · doi:10.18632/oncotarget.2899 · Cited by 40

Functional and Phylogenetic Diversity of BSH and PVA Enzymes

Daly, J. W., Keely, S. J., & Gahan, C. G. M. (2021) · Microorganisms · doi:10.3390/microorganisms9040732 · Cited by 40

Ligand-independent actions of the orphan receptors/corepressors DAX-1 and SHP in metabolism, reproduction and disease

Ehrlund, A., & Treuter, E. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.04.007 · Cited by 38

Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2

Kim, Y., Byun, S., Zhang, Y., Seok, S., KEMPER, B. W., Ma, J., & Kemper, J. K. (2015) · Genome biology · doi:10.1186/s13059-015-0835-6 · Cited by 36

A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion

Picard, A., Soyer, J., Berney, X., Tarussio, D., Quenneville, S., Jan, M., Grouzmann, E., Burdet, F., Ibberson, M., & Thorens, B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.041 · Cited by 35

Fibroblast Growth Factor 19: Potential modulation of hepatic metabolism for the treatment of non‐alcoholic fatty liver disease

Sciarrillo, C. M., Keirns, B. H., Koemel, N. A., Anderson, K. L., & Emerson, S. R. (2021) · Liver International · doi:10.1111/liv.14802 · Cited by 35

Significance of plasma 7α-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits

Honda, A., Yoshida, T., Xu, G., Matsuzaki, Y., Fukushima, S., Tanaka, N., Doy, M., Shefer, S., & Salen, G. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.018 · Cited by 33

Molecular Regulation of Canalicular ABC Transporters

Saad, A. B., Bruneau, A., Mareux, E., Lapalus, M., Delaunay, J.-L., Gonzales, E. M., Jacquemin, E., Aït‐Slimane, T., & Falguières, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042113 · Cited by 33

Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway

Zhang, T., Feng, S., Li, J., Wu, Z., Deng, Q., Yang, W., Li, J., & Pan, G. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03266-6 · Cited by 32

Curtailing FGF19’s mitogenicity by suppressing its receptor dimerization ability

Niu, J., Zhao, J., Wu, J., Qiao, G., Gu, J., Zhou, C., Li, Q., Lei, Y., Wang, D., Lin, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010984117 · Cited by 30

In vitro farnesoid X receptor ligand sensor assay using surface plasmon resonance and based on ligand-induced coactivator association

Fujino, T., Sato, Y., Une, M., Kanayasu‐Toyoda, T., Yamaguchi, T., Shudo, K., Inoue, K., & Nishimaki‐Mogami, T. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.09.008 · Cited by 28

Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice

Yu, X. X., Watts, L. M., Manchem, V. P., Chakravarty, K., Monia, B. P., McCaleb, M. L., & Bhanot, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066923 · Cited by 28

Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH

Welch, R. D., Billon, C., Losby, M., Bedia‐Diaz, G., Fang, Y., Avdagic, A., Elgendy, B., Burris, T. P., & Griffett, K. (2022) · Metabolites · doi:10.3390/metabo12030238 · Cited by 28

Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets

Maliha, S., & Guo, G. L. (2021) · Liver Research · doi:10.1016/j.livres.2021.02.002 · Cited by 26

Fgf15 Neurons of the Dorsomedial Hypothalamus Control Glucagon Secretion and Hepatic Gluconeogenesis

Picard, A., Metref, S., Tarussio, D., Dolci, W., Berney, X. P., Croizier, S., Labouèbe, G., & Thorens, B. (2021) · Diabetes · doi:10.2337/db20-1121 · Cited by 22

FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL/6 mice

Hoekstra, M., van der Sluis, R. J., Li, Z., Oosterveer, M. H., Groen, A. K., & van Berkel, T. J. C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.010 · Cited by 20

Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function

Williams, C. M., Calderon, J. H., Hock, E., Jimenez, Y., Barringer, K., Carbonaro, M., Molina‐Portela, M. D. P., Thurston, G., Li, Z., & Daly, C. (2021) · The FASEB Journal · doi:10.1096/fj.202002203r · Cited by 19

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening

Diao, Y., Jiang, J., Zhang, S., Li, S., Shan, L., Huang, J. Y., Zhang, W., & Li, H. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00140 · Cited by 18

Sodium taurocholate co-transporting polypeptide deficiency

Schneider, A., Kohler, H. G., Röthlisberger, B., Grobholz, R., & McLin, V. A. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101824 · Cited by 18

Targeting the gut microbiota for treating colitis: Is FGF19 a magic bullet?

Chiang, J. Y. L., & Ferrell, J. M. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102754 · Cited by 9

Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice

Lukovac, S., Los, E., Stellaard, F., Rings, E. H. H. M., & Verkade, H. J. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2009 · Cited by 8

A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)

Roberts, S. K., & Majeed, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1999416 · Cited by 8

Fibroblast growth factor 19 stimulates water intake

Bedoya, J. U., Chavey, C., Desandré, G., Meunier, L., Dupuy, A., Dopeso‐Reyes, I. G., Tordjmann, T., Assénat, E., Hibner, U., & Grégoire, D. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101483 · Cited by 5

Fibroblast Growth Factor 19 Activates the Unfolded Protein Response and Mitogen-Activated Protein Kinase Phosphorylation in H-69 Cholangiocyte Cells

Qureshi, H. A. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000158 · Cited by 4

Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis

Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415

A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)

Zhou, S., You, H., Qiu, S., Yu, D., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113577 · Cited by 71

Gut Microbiota Dysbiosis and Its Impact on Type 2 Diabetes: From Pathogenesis to Therapeutic Strategies

Yu, Y., Ding, Y., Wang, S., & Jiang, L. (2025) · Metabolites · doi:10.3390/metabo15060397 · Cited by 72

Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice

Li, S., Zhuge, A., Chen, H., Han, S., Shen, J. F., Wang, K., Xia, J., He, X., Jiang, S., Wu, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.026 · Cited by 51

Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids

Wang, S., Xu, C., Liu, H., Wei, W., Zhou, X., Qian, H., Zhou, L., Zhang, H., Wu, L. M., Chen, Z., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03340-9 · Cited by 51

Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling

Ciaula, A. D., Bonfrate, L., Baj, J., Khalil, M., Garruti, G., Stellaard, F., Wang, H. H., Wang, D. Q. ‐., & Portincasa, P. (2022) · Nutrients · doi:10.3390/nu14234950 · Cited by 76

Bile Acids as Hormones: The FXR-FGF15/19 Pathway

Kliewer, S. A., & Mangelsdorf, D. J. (2015) · Digestive Diseases · doi:10.1159/000371670 · Cited by 424

Nuclear bile acid signaling through the farnesoid X receptor

Mazuy, C., Helleboid‐Chapman, A., Staels, B., & Lefèbvre, P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1805-y · Cited by 113

The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling

Wang, L. X., Frey, M. R., & Kohli, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.799648 · Cited by 42

Endocrine Actions of Bile Acids Via Nuclear Receptors and FGFs

Inagaki, T., Choi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2007) · The FASEB Journal · doi:10.1096/fasebj.21.5.a147-a